How I'd play the Golden Arches after its quarter pounding.
Negotiations on the next round of stimulus, more so than tension between Washington and Beijing, and more so than earnings season, will control short-term financial market performance.
Precious metals are an exception but electric vehicles and SPACs have lost their luster.
Some form of fiscal compromise is widely expected, but I see three risks.
Pay attention to the price action, don't tell the markets what they should be doing, and have some protection on at all times.
I'm looking for some financial names that still offer value in a very uncertain market.
Monetary policy, fiscal policy, and major earnings news are all on the docket.
Why aren't we figuring out how to cure the test bottleneck?
The wise man considers the 'ifs' - the contrary - and constantly evaluates, and often rallies against, 'group stink'.
Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.